Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 25 November 1988:
Vol. 242. no. 4882, pp. 1171 - 1173
DOI: 10.1126/science.2460925

Articles

Science, Vol 242, Issue 4882, 1171-1173
Copyright © 1988 by American Association for the Advancement of Science


articles

The accuracy of reverse transcriptase from HIV-1

JD Roberts, K Bebenek, and TA Kunkel

Laboratory of Molecular Genetics, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709.

A study was conducted to determine the fidelity of DNA synthesis catalyzed in vitro by the reverse transcriptase from a human immunodeficiency virus type 1 (HIV-1). Like other retroviral reverse transcriptases, the HIV-1 enzyme does not correct errors by exonucleolytic proofreading. Measurements with M13mp2-based fidelity assays indicated that the HIV-1 enzyme, isolated either from virus particles or from Escherichia coli cells infected with a plasmid expressing the cloned gene, was exceptionally inaccurate, having an average error rate per detectable nucleotide incorporated of 1/1700. It was, in fact, the least accurate reverse transcriptase described to date, one-tenth as accurate as the polymerases isolated from avian myeloblastosis or murine leukemia viruses, which have average error rates of approximately 1/17,000 and approximately 1/30,000, respectively. DNA sequence analyses of mutations generated by HIV-1 polymerase showed that base substitution, addition, and deletion errors were all produced. Certain template positions were mutational hotspots where the error rate could be as high as 1 per 70 polymerized nucleotides. The data are consistent with the notion that the exceptional diversity of the HIV-1 genome results from error-prone reverse transcription.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Recombination analysis and structure prediction show correlation between breakpoint clusters and RNA hairpins in the pol gene of human immunodeficiency virus type 1 unique recombinant forms.
A. Galli, A. Lai, S. Corvasce, F. Saladini, C. Riva, L. Deho, I. Caramma, M. Franzetti, L. Romano, M. Galli, et al. (2008)
J. Gen. Virol. 89, 3119-3125
   Abstract »    Full Text »    PDF »
Analysis of Natural Sequence Variation and Covariation in Human Immunodeficiency Virus Type 1 Integrase.
R. E. Myers and D. Pillay (2008)
J. Virol. 82, 9228-9235
   Abstract »    Full Text »    PDF »
HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excision.
K. A. Delviks-Frankenberry, G. N. Nikolenko, P. L. Boyer, S. H. Hughes, J. M. Coffin, A. Jere, and V. K. Pathak (2008)
PNAS 105, 10943-10948
   Abstract »    Full Text »    PDF »
Comparison of the Thermal Stabilities of Reverse Transcriptases from Avian Myeloblastosis Virus and Moloney Murine Leukaemia Virus.
K. Yasukawa, D. Nemoto, and K. Inouye (2008)
J. Biochem. 143, 261-268
   Abstract »    Full Text »    PDF »
Reverse transcription of the HIV-1 pandemic.
A. Basavapathruni and K. S. Anderson (2007)
FASEB J 21, 3795-3808
   Abstract »    Full Text »    PDF »
Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness.
C. Dykes and L. M. Demeter (2007)
Clin. Microbiol. Rev. 20, 550-578
   Abstract »    Full Text »    PDF »
Human Immunodeficiency Virus Type 1 Subtype Distribution in the Worldwide Epidemic: Pathogenetic and Therapeutic Implications.
L. Buonaguro, M. L. Tornesello, and F. M. Buonaguro (2007)
J. Virol. 81, 10209-10219
   Full Text »    PDF »
Insights into the Multiple Roles of Pausing in HIV-1 Reverse Transcriptase-promoted Strand Transfers.
L. Gao, M. Balakrishnan, B. P. Roques, and R. A. Bambara (2007)
J. Biol. Chem. 282, 6222-6231
   Abstract »    Full Text »    PDF »
Role of Invariant Thr80 in Human Immunodeficiency Virus Type 1 Protease Structure, Function, and Viral Infectivity.
J. E. Foulkes, M. Prabu-Jeyabalan, D. Cooper, G. J. Henderson, J. Harris, R. Swanstrom, and C. A. Schiffer (2006)
J. Virol. 80, 6906-6916
   Abstract »    Full Text »    PDF »
Nucleotide Excision Repair and Template-independent Addition by HIV-1 Reverse Transcriptase in the Presence of Nucleocapsid Protein.
C. Bampi, A. Bibillo, M. Wendeler, G. Divita, R. J. Gorelick, S. F. J. Le Grice, and J.-L. Darlix (2006)
J. Biol. Chem. 281, 11736-11743
   Abstract »    Full Text »    PDF »
Structural Determinants of Slippage-mediated Mutations by Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
M. E. Hamburgh, K. A. Curr, M. Monaghan, V. R. Rao, S. Tripathi, B. D. Preston, S. Sarafianos, E. Arnold, T. Darden, and V. R. Prasad (2006)
J. Biol. Chem. 281, 7421-7428
   Abstract »    Full Text »    PDF »
Influence of naturally occurring insertions in the fingers subdomain of human immunodeficiency virus type 1 reverse transcriptase on polymerase fidelity and mutation frequencies in vitro.
K. Curr, S. Tripathi, J. Lennerstrand, B. A. Larder, and V. R. Prasad (2006)
J. Gen. Virol. 87, 419-428
   Abstract »    Full Text »    PDF »
Preliminary Mapping of a Putative Inhibitor-Binding Pocket for Human Immunodeficiency Virus Type 1 Integrase Inhibitors.
D. J. Lee and W. E. Robinson Jr. (2006)
Antimicrob. Agents Chemother. 50, 134-142
   Abstract »    Full Text »    PDF »
Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution.
T. M. Allen, M. Altfeld, S. C. Geer, E. T. Kalife, C. Moore, K. M. O'Sullivan, I. DeSouza, M. E. Feeney, R. L. Eldridge, E. L. Maier, et al. (2005)
J. Virol. 79, 13239-13249
   Abstract »    Full Text »    PDF »
A statistical model for HIV-1 sequence classification using the subtype analyser (STAR).
R. E. Myers, C. V. Gale, A. Harrison, Y. Takeuchi, and P. Kellam (2005)
Bioinformatics 21, 3535-3540
   Abstract »    Full Text »    PDF »
Molecular Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm.
C. Apetrei, A. Kaur, N. W. Lerche, M. Metzger, I. Pandrea, J. Hardcastle, S. Falkenstein, R. Bohm, J. Koehler, V. Traina-Dorge, et al. (2005)
J. Virol. 79, 8991-9005
   Abstract »    Full Text »    PDF »
Mechanism of Anti-Human Immunodeficiency Virus Activity of {beta}-D-6-Cyclopropylamino-2',3'-Didehydro-2',3'-Dideoxyguanosine.
A. S. Ray, B. I. Hernandez-Santiago, J. S. Mathew, E. Murakami, C. Bozeman, M.-Y. Xie, G. E. Dutschman, E. Gullen, Z. Yang, S. Hurwitz, et al. (2005)
Antimicrob. Agents Chemother. 49, 1994-2001
   Abstract »    Full Text »    PDF »
Mechanistic Differences in RNA-dependent DNA Polymerization and Fidelity between Murine Leukemia Virus and HIV-1 Reverse Transcriptases.
M. Skasko, K. K. Weiss, H. M. Reynolds, V. Jamburuthugoda, K. Lee, and B. Kim (2005)
J. Biol. Chem. 280, 12190-12200
   Abstract »    Full Text »    PDF »
Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis.
S. Palmer, M. Kearney, F. Maldarelli, E. K. Halvas, C. J. Bixby, H. Bazmi, D. Rock, J. Falloon, R. T. Davey Jr., R. L. Dewar, et al. (2005)
J. Clin. Microbiol. 43, 406-413
   Abstract »    Full Text »    PDF »
Structural Basis for Coevolution of a Human Immunodeficiency Virus Type 1 Nucleocapsid-p1 Cleavage Site with a V82A Drug-Resistant Mutation in Viral Protease.
M. Prabu-Jeyabalan, E. A. Nalivaika, N. M. King, and C. A. Schiffer (2004)
J. Virol. 78, 12446-12454
   Abstract »    Full Text »    PDF »
Novel Mechanism of Inhibition of HIV-1 Reverse Transcriptase by a New Non-nucleoside Analog, KM-1.
L. Z. Wang, G. L. Kenyon, and K. A. Johnson (2004)
J. Biol. Chem. 279, 38424-38432
   Abstract »    Full Text »    PDF »
Role of Minority Populations of Human Immunodeficiency Virus Type 1 in the Evolution of Viral Resistance to Protease Inhibitors.
C. Charpentier, D. E. Dwyer, F. Mammano, D. Lecossier, F. Clavel, and A. J. Hance (2004)
J. Virol. 78, 4234-4247
   Abstract »    Full Text »    PDF »
HIV Drug Resistance.
F. Clavel and A. J. Hance (2004)
N. Engl. J. Med. 350, 1023-1035
   Full Text »    PDF »
Unselected Mutations in the Human Immunodeficiency Virus Type 1 Genome Are Mostly Nonsynonymous and Often Deleterious.
F. Gao, Y. Chen, D. N. Levy, J. A. Conway, T. B. Kepler, and H. Hui (2004)
J. Virol. 78, 2426-2433
   Abstract »    Full Text »    PDF »
Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 {gamma}-{sigma}1 and AP-3 {delta}-{sigma}3 hemicomplexes.
K. Janvier, Y. Kato, M. Boehm, J. R. Rose, J. A. Martina, B.-Y. Kim, S. Venkatesan, and J. S. Bonifacino (2003)
J. Cell Biol. 163, 1281-1290
   Abstract »    Full Text »    PDF »
Efficiency of a programmed -1 ribosomal frameshift in the different subtypes of the human immunodeficiency virus type 1 group M.
M. BARIL, D. DULUDE, K. GENDRON, G. LEMAY, and L. BRAKIER-GINGRAS (2003)
RNA 9, 1246-1253
   Abstract »    Full Text »    PDF »
In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: determination of hot spots and correlation with sequence similarity.
G. Magiorkinis, D. Paraskevis, A.-M. Vandamme, E. Magiorkinis, V. Sypsa, and A. Hatzakis (2003)
J. Gen. Virol. 84, 2715-2722
   Abstract »    Full Text »    PDF »
A positively charged side chain at position 154 on the {beta}8-{alpha}E loop of HIV-1 RT is required for stable ternary complex formation.
B. Sharma, N. Kaushik, A. Upadhyay, S. Tripathi, K. Singh, and V. N. Pandey (2003)
Nucleic Acids Res. 31, 5167-5174
   Abstract »    Full Text »    PDF »
Template Dimerization Promotes an Acceptor Invasion-Induced Transfer Mechanism during Human Immunodeficiency Virus Type 1 Minus-Strand Synthesis.
M. Balakrishnan, B. P. Roques, P. J. Fay, and R. A. Bambara (2003)
J. Virol. 77, 4710-4721
   Abstract »    Full Text »    PDF »
Major Histocompatibility Complex Heterozygote Superiority during Coinfection.
E. E. McClelland, D. J. Penn, and W. K. Potts (2003)
Infect. Immun. 71, 2079-2086
   Abstract »    Full Text »
Lamivudine Can Exert a Modest Antiviral Effect against Human Immunodeficiency Virus Type 1 Containing the M184V Mutation.
Y. Quan, B. G. Brenner, M. Oliveira, and M. A. Wainberg (2003)
Antimicrob. Agents Chemother. 47, 747-754
   Abstract »    Full Text »    PDF »
The use of tenofovir disoproxil fumarate for the treatment of nucleoside-resistant HIV-1.
D. J. McColl and M. D. Miller (2003)
J. Antimicrob. Chemother. 51, 219-223
   Full Text »    PDF »
Viability of a Drug-Resistant Human Immunodeficiency Virus Type 1 Protease Variant: Structural Insights for Better Antiviral Therapy.
M. Prabu-Jeyabalan, E. A. Nalivaika, N. M. King, and C. A. Schiffer (2002)
J. Virol. 77, 1306-1315
   Abstract »    Full Text »    PDF »
Exploring the Effects of Active Site Constraints on HIV-1 Reverse Transcriptase DNA Polymerase Fidelity.
J. Cramer, M. Strerath, A. Marx, and T. Restle (2002)
J. Biol. Chem. 277, 43593-43598
   Abstract »    Full Text »    PDF »
Mechanistic Studies to Understand the Progressive Development of Resistance in Human Immunodeficiency Virus Type 1 Reverse Transcriptase to Abacavir.
A. S. Ray, A. Basavapathruni, and K. S. Anderson (2002)
J. Biol. Chem. 277, 40479-40490
   Abstract »    Full Text »    PDF »
Human Immunodeficiency Virus Type 1 Recombination: Rate, Fidelity, and Putative Hot Spots.
J. Zhuang, A. E. Jetzt, G. Sun, H. Yu, G. Klarmann, Y. Ron, B. D. Preston, and J. P. Dougherty (2002)
J. Virol. 76, 11273-11282
   Abstract »    Full Text »    PDF »
Mutational Analysis of HIV-1 Long Terminal Repeats to Explore the Relative Contribution of Reverse Transcriptase and RNA Polymerase II to Viral Mutagenesis.
P. K. O'Neil, G. Sun, H. Yu, Y. Ron, J. P. Dougherty, and B. D. Preston (2002)
J. Biol. Chem. 277, 38053-38061
   Abstract »    Full Text »    PDF »
ATP-Dependent Removal of Nucleoside Reverse Transcriptase Inhibitors by Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
L. K. Naeger, N. A. Margot, and M. D. Miller (2002)
Antimicrob. Agents Chemother. 46, 2179-2184
   Abstract »    Full Text »    PDF »
Substitutions of Phe61 Located in the Vicinity of Template 5'-Overhang Influence Polymerase Fidelity and Nucleoside Analog Sensitivity of HIV-1 Reverse Transcriptase.
T. S. Fisher and V. R. Prasad (2002)
J. Biol. Chem. 277, 22345-22352
   Abstract »    Full Text »    PDF »
Functional Correlates of Insertion Mutations in the Protease Gene of Human Immunodeficiency Virus Type 1 Isolates from Patients.
E.-Y. Kim, M. A. Winters, R. M. Kagan, and T. C. Merigan (2001)
J. Virol. 75, 11227-11233
   Abstract »    Full Text »    PDF »
Neither the New Zealand Genetically Hypertensive Strain nor Dahl Salt-Sensitive Strain Has an A1079T Transversion in the {alpha}1 Isoform of the Na+,K+-ATPase Gene.
R. Barnard, G. Kelly, S. O. Manzetti, and E. L. Harris (2001)
Hypertension 38, 786-792
   Abstract »    Full Text »    PDF »
Human Immunodeficiency Virus Type 1 DNA Sequences Genetically Damaged by Hypermutation Are Often Abundant in Patient Peripheral Blood Mononuclear Cells and May Be Generated during Near-Simultaneous Infection and Activation of CD4+ T Cells.
M. Janini, M. Rogers, D. R. Birx, and F. E. McCutchan (2001)
J. Virol. 75, 7973-7986
   Abstract »    Full Text »    PDF »
Genomic Stability of Murine Leukemia Viruses Containing Insertions at the Env-3' Untranslated Region Boundary.
C. R. Logg, A. Logg, C.-K. Tai, P. M. Cannon, and N. Kasahara (2001)
J. Virol. 75, 6989-6998
   Abstract »    Full Text »
Augmentation of Human Immunodeficiency Virus Type 1 Subtype E (CRF01_AE) Multiple-Drug Resistance by Insertion of a Foreign 11-Amino-Acid Fragment into the Reverse Transcriptase.
H. Sato, Y. Tomita, K. Ebisawa, A. Hachiya, K. Shibamura, T. Shiino, R. Yang, M. Tatsumi, K. Gushi, H. Umeyama, et al. (2001)
J. Virol. 75, 5604-5613
   Abstract »    Full Text »
Equine Infectious Anemia Virus Genomic Evolution in Progressor and Nonprogressor Ponies.
C. Leroux, J. K. Craigo, C. J. Issel, and R. C. Montelaro (2001)
J. Virol. 75, 4570-4583
   Abstract »    Full Text »
Independent HIV replication in paired CSF and blood viral isolates during antiretroviral therapy.
K. Stingele, J. Haas, T. Zimmermann, R. Stingele, C. Hubsch-Muller, M. Freitag, B. Storch-Hagenlocher, M. Hartmann, and B. Wildemann (2001)
Neurology 56, 355-361
   Abstract »    Full Text »    PDF »
Clustered Mutations in HIV-1 gag Are Consistently Required for Escape from HLA-B27-restricted Cytotoxic T Lymphocyte Responses.
A. D. Kelleher, C. Long, E. C. Holmes, R. L. Allen, J. Wilson, C. Conlon, C. Workman, S. Shaunak, K. Olson, P. Goulder, et al. (2001)
J. Exp. Med. 193, 375-386
   Abstract »    Full Text »    PDF »
Evolution of the Human Immunodeficiency Virus Type 1 Envelope during Infection Reveals Molecular Corollaries of Specificity for Coreceptor Utilization and AIDS Pathogenesis.
Q.-x. Hu, A. P. Barry, Z.-x. Wang, S. M. Connolly, S. C. Peiper, and M. L. Greenberg (2000)
J. Virol. 74, 11858-11872
   Abstract »    Full Text »
Differential Removal of Thymidine Nucleotide Analogues from Blocked DNA Chains by Human Immunodeficiency Virus Reverse Transcriptase in the Presence of Physiological Concentrations of 2'-Deoxynucleoside Triphosphates.
P. R. Meyer, S. E. Matsuura, R. F. Schinazi, A. G. So, and W. A. Scott (2000)
Antimicrob. Agents Chemother. 44, 3465-3472
   Abstract »    Full Text »
Role of Murine Leukemia Virus Reverse Transcriptase Deoxyribonucleoside Triphosphate-Binding Site in Retroviral Replication and In Vivo Fidelity.
E. K. Halvas, E. S. Svarovskaia, and V. K. Pathak (2000)
J. Virol. 74, 10349-10358
   Abstract »    Full Text »
Immunogenicity of Mutations Induced by Nucleoside Reverse Transcriptase Inhibitors for Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Cells.
A. Samri, G. Haas, J. Duntze, J.-M. Bouley, V. Calvez, C. Katlama, and B. Autran (2000)
J. Virol. 74, 9306-9312
   Abstract »    Full Text »
Effects of Amino Acid Substitutions at Position 115 on the Fidelity of Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
P. L. Boyer and S. H. Hughes (2000)
J. Virol. 74, 6494-6500
   Abstract »    Full Text »
Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants Resistant to the (+) and (-) Enantiomers of 2'-Deoxy-3'-Oxa-4'-Thio-5-Fluorocytidine.
N. Richard, H. Salomon, R. Rando, T. Mansour, T. L. Bowlin, and M. A. Wainberg (2000)
Antimicrob. Agents Chemother. 44, 1127-1131
   Abstract »    Full Text »
T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide.
L. Bouhdoud, P. Villain, A. Merzouki, M. Arella, and C. Couture (2000)
J. Virol. 74, 2121-2130
   Abstract »    Full Text »
Uniquely Altered DNA Replication Fidelity Conferred by an Amino Acid Change in the Nucleotide Binding Pocket of Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
D. A. Lewis, K. Bebenek, W. A. Beard, S. H. Wilson, and T. A. Kunkel (1999)
J. Biol. Chem. 274, 32924-32930
   Abstract »    Full Text »    PDF »
Mutations in the Primer Grip Region of HIV Reverse Transcriptase Can Increase Replication Fidelity.
M. Wisniewski, C. Palaniappan, Z. Fu, S. F. J. Le Grice, P. Fay, and R. A. Bambara (1999)
J. Biol. Chem. 274, 28175-28184
   Abstract »    Full Text »    PDF »
Suppression of Replication of Multidrug-Resistant HIV Type 1 Variants by Combinations of Thymidylate Synthase Inhibitors with Zidovudine or Stavudine.
W.-Y. Gao, D. G. Johns, M. Tanaka, and H. Mitsuya (1999)
Mol. Pharmacol. 55, 535-540
   Abstract »    Full Text »
Coevolutionary analysis of resistance-evading peptidomimetic inhibitors of HIV-1 protease.
C. D. Rosin, R. K. Belew, G. M. Morris, A. J. Olson, and D. S. Goodsell (1999)
PNAS 96, 1369-1374
   Abstract »    Full Text »    PDF »
Lethal mutagenesis of HIV with mutagenic nucleoside analogs.
L. A. Loeb, J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, and J. I. Mullins (1999)
PNAS 96, 1492-1497
   Abstract »    Full Text »    PDF »
Functional Analysis of Amino Acid Residues Constituting the dNTP Binding Pocket of HIV-1 Reverse Transcriptase.
D. Harris, N. Kaushik, P. K. Pandey, P. N. S. Yadav, and V. N. Pandey (1998)
J. Biol. Chem. 273, 33624-33634
   Abstract »    Full Text »    PDF »
Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.
P. R. Meyer, S. E. Matsuura, A. G. So, and W. A. Scott (1998)
PNAS 95, 13471-13476
   Abstract »    Full Text »    PDF »
Deoxyribonucleoside Triphosphate Pool Imbalances In Vivo Are Associated with an Increased Retroviral Mutation Rate.
J. G. Julias and V. K. Pathak (1998)
J. Virol. 72, 7941-7949
   Abstract »    Full Text »    PDF »
Dominance of the E89G Substitution in HIV-1 Reverse Transcriptase in Regard to Increased Polymerase Processivity and Patterns of Pausing.
Y. Quan, P. Inouye, C. Liang, L. Rong, M. Gotte, and M. A. Wainberg (1998)
J. Biol. Chem. 273, 21918-21925
   Abstract »    Full Text »    PDF »
Evolution of Syncytium-Inducing and Non-Syncytium-Inducing Biological Virus Clones in Relation to Replication Kinetics during the Course of Human Immunodeficiency Virus Type 1 Infection.
A. B. van 't Wout, H. Blaak, L. J. Ran, M. Brouwer, C. Kuiken, and H. Schuitemaker (1998)
J. Virol. 72, 5099-5107
   Abstract »    Full Text »    PDF »
The Impact of Multidideoxynucleoside Resistance-Conferring Mutations in Human Immunodeficiency Virus Type 1 Reverse Transcriptase on Polymerase Fidelity and Error Specificity.
L. F. Rezende, K. Curr, T. Ueno, H. Mitsuya, and V. R. Prasad (1998)
J. Virol. 72, 2890-2895
   Abstract »    Full Text »    PDF »
Insertions into the beta 3-beta 4 Hairpin Loop of HIV-1 Reverse Transcriptase Reveal a Role for Fingers Subdomain in Processive Polymerization.
Y. Kew, L. R. Olsen, A. J. Japour, and V. R. Prasad (1998)
J. Biol. Chem. 273, 7529-7537
   Abstract »    Full Text »    PDF »
DNA Mismatch Repair Catalyzed by Extracts of Mitotic, Postmitotic, and Senescent Drosophila Tissues and Involvement of mei-9 Gene Function for Full Activity.
A. Bhui-Kaur, M. F. Goodman, and J. Tower (1998)
Mol. Cell. Biol. 18, 1436-1443
   Abstract »    Full Text »
Flexible Positioning of the Telomerase-Associated Nuclease Leads to Preferential Elimination of Nontelomeric DNA.
E. C. Greene, J. Bednenko, and D. E. Shippen (1998)
Mol. Cell. Biol. 18, 1544-1552
   Abstract »    Full Text »
High Fidelity of Internal Strand Transfer Catalyzed by Human Immunodeficiency Virus Reverse Transcriptase.
J. DeStefano, J. Ghosh, B. Prasad, and A. Raja (1998)
J. Biol. Chem. 273, 1483-1489
   Abstract »    Full Text »    PDF »
Hydrogen bonding revisited: Geometric selection as a principal determinant of DNA replication fidelity.
M. F. Goodman (1997)
PNAS 94, 10493-10495
   Full Text »    PDF »
Stereoisomers of Deoxynucleoside 5'-Triphosphates as Substrates for Template-dependent and -independent DNA Polymerases.
D. G. Semizarov, A. A. Arzumanov, N. B. Dyatkina, A. Meyer, S. Vichier-Guerre, G. Gosselin, B. Rayner, J.-L. Imbach, and A. A. Krayevsky (1997)
J. Biol. Chem. 272, 9556-9560
   Abstract »    Full Text »    PDF »
Differential Tolerance to DNA Polymerization by HIV-1 Reverse Transcriptase on N6 Adenine C10R and C10S Benzo[a]pyrene-7,8-dihydrodiol 9,10-Epoxide-adducted Templates.
P. Chary, C. M. Harris, T. M. Harris, and R. S. Lloyd (1997)
J. Biol. Chem. 272, 5805-5813
   Abstract »    Full Text »    PDF »
Incorporation of the Guanosine Triphosphate Analogs 8-Oxo-dGTP and 8-NH2-dGTP by Reverse Transcriptases and Mammalian DNA Polymerases.
A. S. Kamath-Loeb, A. Hizi, H. Kasai, and L. A. Loeb (1997)
J. Biol. Chem. 272, 5892-5898
   Abstract »    Full Text »    PDF »
Evolutionary mechanisms and population dynamics of the third variable envelope region of HIV within single hosts.
Y. Yamaguchi and T. Gojobori (1997)
PNAS 94, 1264-1269
   Abstract »    Full Text »    PDF »
Misincorporation by HIV-1 Reverse Transcriptase Promotes Recombination via Strand Transfer Synthesis.
C. Palaniappan, M. Wisniewski, W. Wu, P. J. Fay, and R. A. Bambara (1996)
J. Biol. Chem. 271, 22331-22338
   Abstract »    Full Text »    PDF »
Enzyme-DNA Interactions Required for Efficient Nucleotide Incorporation and Discrimination in Human DNA Polymerase beta.
W. A. Beard, W. P. Osheroff, R. Prasad, M. R. Sawaya, M. Jaju, T. G. Wood, J. Kraut, T. A. Kunkel, and S. H. Wilson (1996)
J. Biol. Chem. 271, 12141-12144
   Abstract »    Full Text »    PDF »
Role of the ``Helix Clamp'' in HIV-1 Reverse Transcriptase Catalytic Cycling as Revealed by Alanine-scanning Mutagenesis.
W. A. Beard, D. T. Minnick, C. L. Wade, R. Prasad, R. L. Won, A. Kumar, T. A. Kunkel, and S. H. Wilson (1996)
J. Biol. Chem. 271, 12213-12220
   Abstract »    Full Text »    PDF »
Interface Peptides as Structure-based Human Immunodeficiency Virus Reverse Transcriptase Inhibitors.
G. Divita, J. G. Baillon, K. Rittinger, J.-C. Chermann, and R. S. Goody (1995)
J. Biol. Chem. 270, 28642-28646
   Abstract »    Full Text »    PDF »
Enzymatic Characterization of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Resistant to Multiple 2`,3`-Dideoxynucleoside 5`-Triphosphates.
T. Ueno, T. Shirasaka, and H. Mitsuya (1995)
J. Biol. Chem. 270, 23605-23611
   Abstract »    Full Text »    PDF »
Reduced Frameshift Fidelity and Processivity of HIV-1 Reverse Transcriptase Mutants Containing Alanine Substitutions in Helix H of the Thumb Subdomain.
K. Bebenek, W. A. Beard, J. R. Casas-Finet, H.-R. Kim, T. A. Darden, S. H. Wilson, and T. A. Kunkel (1995)
J. Biol. Chem. 270, 19516-19523
   Abstract »    Full Text »    PDF »
Influence of Human Immunodeficiency Virus Nucleocapsid Protein on Synthesis and Strand Transfer by the Reverse Transcriptase in Vitro.
L. Rodrguez-Rodrguez, Z. Tsuchihashi, G. M. Fuentes, R. A. Bambara, and P. J. Fay (1995)
J. Biol. Chem. 270, 15005-15011
   Abstract »    Full Text »    PDF »
Mechanism of DNA strand transfer reactions catalyzed by HIV-1 reverse transcriptase.
J. Peliska and S. Benkovic (1992)
Science 258, 1112-1118
   Abstract »    PDF »
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor.
L. Kohlstaedt, J Wang, J. Friedman, P. Rice, and T. Steitz (1992)
Science 256, 1783-1790
   Abstract »    PDF »
Selective transmission of human immunodeficiency virus type-1 variants from mothers to infants.
S. Wolinsky, C. Wike, B. Korber, C Hutto, W. Parks, L. Rosenblum, K. Kunstman, M. Furtado, and J. Munoz (1992)
Science 255, 1134-1137
   Abstract »    PDF »
Antigenic diversity thresholds and the development of AIDS.
M. Nowak, R. Anderson, A. McLean, T. Wolfs, J Goudsmit, and R. May (1991)
Science 254, 963-969
   Abstract »    PDF »
Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase.
M. St Clair, J. Martin, G Tudor-Williams, M. Bach, C. Vavro, D. King, P Kellam, S. Kemp, and B. Larder (1991)
Science 253, 1557-1559
   Abstract »    PDF »
DNA polymerase fidelity and the polymerase chain reaction..
K A Eckert and T A Kunkel (1991)
Genome Res. 1, 17-24
   Abstract »    PDF »
Molecular targets for AIDS therapy.
H Mitsuya, R Yarchoan, and S Broder (1990)
Science 249, 1533-1544
   Abstract »    PDF »
Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
B. Larder and S. Kemp (1989)
Science 246, 1155-1158
   Abstract »    PDF »
Vertical-scanning Mutagenesis of a Critical Tryptophan in the "Minor Groove Binding Track" of HIV-1 Reverse Transcriptase. MAJOR GROOVE DNA ADDUCTS IDENTIFY SPECIFIC PROTEIN INTERACTIONS IN THE MINOR GROOVE.
G. J. Latham, E. Forgacs, W. A. Beard, R. Prasad, K. Bebenek, T. A. Kunkel, S. H. Wilson, and R. S. Lloyd (2000)
J. Biol. Chem. 275, 15025-15033
   Abstract »    Full Text »    PDF »
Analysis of Efficiency and Fidelity of HIV-1 (+)-Strand DNA Synthesis Reveals a Novel Rate-limiting Step during Retroviral Reverse Transcription.